
Overlap Results

Collection(s):	BP, C1, C6, CGP, CM, CP, CP:KEGG, MIR, TFT
# overlaps shown:	100
# genesets in collections:	7332
# genes in comparison (n):	250
# genes in universe (N):	45956

Gene Set Name	# Genes in Gene Set (K)	Description	# Genes in Overlap (k)	k/K	p-value	FDR q-value
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	570	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	97	0.1702	7.78E-119	5.71E-115
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	140	The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.	65	0.4643	3.55E-111	1.3E-107
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	456	Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.	82	0.1798	1.67E-101	4.09E-98
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1375	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	109	0.0793	2.49E-97	4.56E-94
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	151	Up-regulated genes whose expression correlated with histologic grade of invasive breast cancer tumors: comparison of grade 1 vs grade 3.	60	0.3974	3.34E-97	4.89E-94
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1278	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	106	0.0829	1.95E-96	2.39E-93
MODULE_54	263	Genes in the cancer module 54	68	0.2586	2.34E-95	2.45E-92
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	324	Genes up-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	70	0.2160	3.98E-92	3.64E-89
HORIUCHI_WTAP_TARGETS_DN	310	Genes down-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.	67	0.2161	4.64E-88	3.78E-85
KOBAYASHI_EGFR_SIGNALING_24HR_DN	251	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	62	0.2470	2.53E-85	1.86E-82
CHANG_CYCLING_GENES	148	Fibroblast serum response genes showing periodic expression during the cell cycle; excluded from the core serum response signature.	51	0.3446	1.59E-78	1.06E-75
MARSON_BOUND_BY_E2F4_UNSTIMULATED	728	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	78	0.1071	6.69E-78	4.09E-75
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	178	Top 200 marker genes up-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	52	0.2921	1.16E-75	6.54E-73
LEE_EARLY_T_LYMPHOCYTE_UP	107	Genes up-regulated at early stages of progenitor T lymphocyte maturation compared to the late stages.	43	0.4019	1.13E-69	5.94E-67
NUYTTEN_EZH2_TARGETS_DN	1024	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	80	0.0781	5.83E-69	2.85E-66
BENPORATH_CYCLING_GENES	648	Genes showing cell-cycle stage-specific expression [PMID=12058064].	69	0.1065	2.62E-68	1.2E-65
VECCHI_GASTRIC_CANCER_EARLY_UP	430	Up-regulated genes distinguishing between early gastric cancer (EGC) and normal tissue samples.	61	0.1419	5.73E-68	2.47E-65
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	181	Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.	46	0.2541	1.16E-63	4.71E-61
ODONNELL_TFRC_TARGETS_DN	139	Genes down-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) upon knockdown of TFRC [GeneID=7037] by RNAi.	42	0.3022	9.6E-62	3.7E-59
ZHANG_TLX_TARGETS_60HR_DN	277	Genes down-regulated in neural stem cells (NSC) at 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	50	0.1805	4.77E-61	1.67E-58
KONG_E2F3_TARGETS	97	Genes up-regulated in MEF cells (embryonic fibroblasts) at 16 hr after serum stimulation and knockdown of E2F3 [GeneID=1871] by RNAi.	38	0.3918	4.78E-61	1.67E-58
CROONQUIST_IL6_DEPRIVATION_DN	98	Genes down-regulated in the ANBL-6 cell line (multiple myeloma, MM) after withdrawal of IL6 [GeneID=3569].	38	0.3878	7.77E-61	2.59E-58
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	146	Genes up-regulated in CD4+ [GeneID=920] T lymphocytes after stimulation with prostaglandin E2 [PubChem=5280360].	42	0.2877	1.06E-60	3.39E-58
GOLDRATH_ANTIGEN_RESPONSE	346	Genes up-regulated at the peak of an antigen response of naive CD8+ [GeneID=925;926] T-cells.	51	0.1474	1.65E-57	4.88E-55
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	128	Cell cycle genes significantly (p =< 0.05) changed in fibroblast cells at 24 h after exposure to ionizing radiation.	39	0.3047	1.67E-57	4.88E-55
WHITEFORD_PEDIATRIC_CANCER_MARKERS	116	Differentially expressed genes in a panel of xenografts representing 8 common pediatric tumors compared to the normal tissues.	38	0.3276	1.89E-57	5.34E-55
PUJANA_BRCA1_PCC_NETWORK	1652	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	84	0.0508	2.14E-57	5.82E-55
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	87	Top 100 probe sets contrubuting to the positive side of the 2nd principal component; associated with adipocytic differentiation.	35	0.4023	9.26E-57	2.43E-54
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	162	Genes from the 254-gene classifier which were up-regulated in melanoma patients with a reported distant metastasis within 4 years.	41	0.2531	1.21E-56	3.05E-54
BASAKI_YBX1_TARGETS_UP	290	Genes up-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	47	0.1621	5.31E-55	1.3E-52
PUJANA_CHEK2_PCC_NETWORK	779	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC >= 0.4) with that of CHEK2 [GeneID=11200].	63	0.0809	1.37E-54	3.23E-52
PATIL_LIVER_CANCER	747	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	62	0.0830	2.18E-54	5E-52
KANG_DOXORUBICIN_RESISTANCE_UP	54	Genes up-regulated in gastric cancer cell lines: doxorubicin [PubChem=31703] resistant vs sensitive.	30	0.5556	2.42E-54	5.37E-52
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	163	Genes up-regulated during differentiation from large pre-BII to small pre-BII lymphocyte.	39	0.2393	8.11E-53	1.75E-50
ZHAN_MULTIPLE_MYELOMA_PR_UP	45	Top 50 up-regulated genes in cluster PR of multiple myeloma samples characterized by increased expression of proliferation and cell cycle genes.	28	0.6222	8.44E-53	1.77E-50
WONG_EMBRYONIC_STEM_CELL_CORE	335	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	47	0.1403	6.7E-52	1.36E-49
GAVIN_FOXP3_TARGETS_CLUSTER_P6	91	Cluster P6 of genes with similar expression profiles in peripheral T lymphocytes after FOXP3 [GeneID=50943] loss of function (LOF).	33	0.3626	1.06E-51	2.1E-49
CAIRO_HEPATOBLASTOMA_CLASSES_UP	605	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	56	0.0926	1.25E-51	2.41E-49
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	378	Down-regulated genes whose expression profile is specific to Custer I of urothelial cell carcinoma (UCC) tumors.	47	0.1243	2.42E-49	4.55E-47
CROONQUIST_NRAS_SIGNALING_DN	72	Genes down-regulated in ANBL-6 cell line (multiple myeloma, MM)  expressing a constantly active form of NRAS [GeneID=4893] off a plasmid vector compared to those grown in the presence of IL6 [GeneID=3569].	30	0.4167	2.6E-49	4.77E-47
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	329	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	45	0.1368	3.66E-49	6.55E-47
BERENJENO_TRANSFORMED_BY_RHOA_UP	536	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	52	0.0970	6.12E-49	1.07E-46
BURTON_ADIPOGENESIS_3	101	Strongly up-regulated at 16-24 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.	32	0.3168	6.7E-48	1.14E-45
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	722	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	56	0.0776	2.36E-47	3.93E-45
BLUM_RESPONSE_TO_SALIRASIB_DN	342	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	44	0.1287	7.47E-47	1.22E-44
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	663	Genes down-regulated in APL (acute promyeolocytic leukemia) blasts expressing PML-RARA fusion [GeneID=5371;5914] compared to normal promyeloblasts.	54	0.0814	9.28E-47	1.48E-44
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	87	Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	30	0.3448	2.9E-46	4.52E-44
MORI_IMMATURE_B_LYMPHOCYTE_DN	90	Down-regulated genes in the B lymphocyte developmental signature based on expression profiling of lymphomas from the Emu-myc transgenic mice: the immature B stage.	30	0.3333	9.81E-46	1.5E-43
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	633	Genes up-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	52	0.0821	3.45E-45	5.16E-43
MARKEY_RB1_ACUTE_LOF_DN	228	Genes down-regulated in adult fibroblasts with inactivated RB1 [GeneID=5925] by Cre-lox: acute loss of function (LOF) of RB1.	38	0.1667	5.8E-45	8.5E-43
MODULE_52	433	Genes in the cancer module 52	45	0.1039	1.19E-43	1.71E-41
PUJANA_BRCA2_PCC_NETWORK	423	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	44	0.1040	1.07E-42	1.51E-40
GEORGES_TARGETS_OF_MIR192_AND_MIR215	893	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	56	0.0627	2.6E-42	3.6E-40
FUJII_YBX1_TARGETS_DN	202	Genes down-regulated in MCF-7 cells (breast cancer) after knockdown of YBX1 [GeneID=4904] by RNAi.	35	0.1733	4.46E-42	6.06E-40
BENPORATH_PROLIFERATION	147	Set 'Proliferation Cluster': genes defined in human breast tumor expression data.	32	0.2177	5.81E-42	7.74E-40
TANG_SENESCENCE_TP53_TARGETS_DN	57	Genes down-regulated in WI-38 cells (senescent primary fibroblasts) after inactivation of TP53 [GeneID=7157] by GSE56 polypeptide.	25	0.4386	6.1E-42	7.98E-40
MODULE_118	410	Genes in the cancer module 118	43	0.1049	6.98E-42	8.98E-40
POOLA_INVASIVE_BREAST_CANCER_UP	288	Genes up-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).	38	0.1319	6.46E-41	8.17E-39
MODULE_53	405	Genes in the cancer module 53	42	0.1037	1.06E-40	1.31E-38
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	163	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	32	0.1963	2.16E-40	2.64E-38
AMUNDSON_GAMMA_RADIATION_RESPONSE	40	Genes down-regulated across the entire panel of NCI-60 cell lines in response to gamma radiation.	22	0.5500	6.16E-40	7.4E-38
FEVR_CTNNB1_TARGETS_DN	553	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	45	0.0814	7.15E-39	8.46E-37
SMID_BREAST_CANCER_BASAL_UP	648	Genes up-regulated in basal subtype of breast cancer samles.	47	0.0725	2.67E-38	3.11E-36
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	309	Genes down-regulated in mature plasma cells compared with plasmablastic B lymphocytes.	37	0.1197	3.05E-38	3.49E-36
AFFAR_YY1_TARGETS_DN	234	Genes down-regulated in MEF cells (embryonic fibroblast) expressing ~25% of YY1 [GeneID=7528].	34	0.1453	3.84E-38	4.33E-36
FARMER_BREAST_CANCER_CLUSTER_2	33	Cluster 2: selected proliferation and 8q amplicon genes clustered together across breast cancer samples.	20	0.6061	1.28E-37	1.42E-35
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	294	Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.	36	0.1224	1.4E-37	1.53E-35
MODULE_3	385	Genes in the cancer module 3	39	0.1013	2.08E-37	2.24E-35
MODULE_18	451	Genes in the cancer module 18	41	0.0909	2.21E-37	2.35E-35
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	250	The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.	34	0.1360	4E-37	4.19E-35
JOHNSTONE_PARVB_TARGETS_3_DN	918	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	52	0.0566	4.97E-37	5.13E-35
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	463	Genes down-regulated in HCT116 cells (colon cancer) upon expression of MIR34B or MIR34C [GeneID=407041;407042] microRNAs.	41	0.0886	6.48E-37	6.59E-35
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	86	Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the  Large Pre-BII stage.	25	0.2907	1.65E-36	1.65E-34
WHITFIELD_CELL_CYCLE_G2_M	216	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G2/M phase of cell cycle.	32	0.1481	3.21E-36	3.18E-34
CELL_CYCLE_PROCESS	193	Genes annotated by the GO term GO:0022402. A cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.	30	0.1554	1.16E-34	1.14E-32
MITOTIC_CELL_CYCLE	153	Genes annotated by the GO term GO:0000278. Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.	28	0.1830	1.61E-34	1.55E-32
CHICAS_RB1_TARGETS_GROWING	243	Genes up-regulated in growing IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	32	0.1317	1.63E-34	1.55E-32
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	277	Genes identified by method 2 as coordinately down-regulated late in HMEC cells (mammary epithelium) during acinar development in vitro.	33	0.1191	4.29E-34	4.03E-32
MORI_PRE_BI_LYMPHOCYTE_UP	80	Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the Pre-BI stage.	23	0.2875	1.53E-33	1.42E-31
RHODES_UNDIFFERENTIATED_CANCER	69	Genes commonly up-regulated in undifferentiated cancer relative to well-differentiated cancer, based on the meta-analysis of the OncoMine gene expression database.	22	0.3188	2.78E-33	2.55E-31
WEST_ADRENOCORTICAL_TUMOR_UP	294	Up-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	33	0.1122	3.19E-33	2.89E-31
CELL_CYCLE_PHASE	170	Genes annotated by the GO term GO:0022403. A cell cycle process comprising the steps by which a cell progresses through one of the biochemical and morphological phases and events that occur during successive cell replication or nuclear replication events.	28	0.1647	3.76E-33	3.36E-31
KIM_WT1_TARGETS_DN	459	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	38	0.0828	3.9E-33	3.44E-31
M_PHASE	114	Genes annotated by the GO term GO:0000279. Progression through M phase, the part of the cell cycle comprising nuclear division.	25	0.2193	4.66E-33	4.07E-31
M_PHASE_OF_MITOTIC_CELL_CYCLE	85	Genes annotated by the GO term GO:0000087. Progression through M phase, the part of the mitotic cell cycle during which mitosis takes place.	23	0.2706	7.57E-33	6.46E-31
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	85	Cell cycle genes significantly (p =< 0.05) changed in fibroblast cells at 6 h after exposure to ionizing radiation.	23	0.2706	7.57E-33	6.46E-31
MITSIADES_RESPONSE_TO_APLIDIN_DN	249	Genes down-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	31	0.1245	1.11E-32	9.39E-31
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	180	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	28	0.1556	2.04E-32	1.7E-30
CELL_CYCLE_GO_0007049	315	Genes annotated by the GO term GO:0007049. The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.	33	0.1048	3.21E-32	2.65E-30
ZHANG_TLX_TARGETS_36HR_DN	185	Genes down-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	28	0.1514	4.58E-32	3.73E-30
WHITFIELD_CELL_CYCLE_LITERATURE	44	A list of known cell cycle regulated genes that was compiled from the literature by the authors.	19	0.4318	5.89E-32	4.75E-30
LE_EGR2_TARGETS_UP	108	Genes up-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959].	24	0.2222	6.28E-32	5E-30
BIDUS_METASTASIS_UP	214	Genes up-regulated in endometroid endometrial tumors from patients with lymph node metastases compared to those without the metastases.	29	0.1355	9.99E-32	7.88E-30
GAL_LEUKEMIC_STEM_CELL_DN	244	Genes down-regulated in leukemic stem cells (LSC), defined as CD34+CD38- [GeneID=947;952] cells from AML (acute myeloid leukemia patients) compared to the CD34+CD38+ cells.	30	0.1230	1.75E-31	1.36E-29
MITOSIS	82	Genes annotated by the GO term GO:0007067. Progression through mitosis, the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.	22	0.2683	2.26E-31	1.74E-29
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	374	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	34	0.0909	4.49E-31	3.43E-29
WHITFIELD_CELL_CYCLE_G2	182	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G2 phase of cell cycle.	27	0.1484	1.05E-30	7.9E-29
REACTOME_CELL_CYCLE	421	Genes involved in Cell Cycle	35	0.0831	1.27E-30	9.5E-29
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	122	Genes down-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	24	0.1967	1.54E-30	1.14E-28
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	185	Human orthologs of genes down-regulated in the crb ('crash and burn') zebrafish mutant that represents a loss-of-function mutation in BMYB [GeneID=4605].	27	0.1459	1.66E-30	1.22E-28


Gene/Gene Set Overlap Matrix

Entrez Gene Id	Gene Symbol	Gene Description	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN	WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
7153	TOP2A	topoisomerase (DNA) II alpha 170kDa	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN			MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				CHICAS_RB1_TARGETS_GROWING		MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN	WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN			WHITFIELD_CELL_CYCLE_G2			
332	BIRC5	baculoviral IAP repeat containing 5	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP			KANG_DOXORUBICIN_RESISTANCE_UP		ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			MARKEY_RB1_ACUTE_LOF_DN					BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP				FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN					ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE		MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS			REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
9787	DLGAP5	discs, large (Drosophila) homolog-associated protein 5	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE				RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049				BIDUS_METASTASIS_UP						MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
983	CDK1	cyclin-dependent kinase 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN					SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN			WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
701	BUB1B	budding uninhibited by benzimidazoles 1 homolog beta (yeast)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP		BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP				PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP		ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN				RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN			MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C			CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE		MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE			GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
51203	NUSAP1	nucleolar and spindle associated protein 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP		BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP				PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN				FUJII_YBX1_TARGETS_DN		TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP					SMID_BREAST_CANCER_BASAL_UP			FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2				CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN		LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS		WHITFIELD_CELL_CYCLE_G2		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
22974	TPX2	TPX2, microtubule-associated, homolog (Xenopus laevis)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP			WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP		ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN				RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN						MODULE_52	PUJANA_BRCA2_PCC_NETWORK				TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			SMID_BREAST_CANCER_BASAL_UP			FARMER_BREAST_CANCER_CLUSTER_2		MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP				WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE		MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN			BIDUS_METASTASIS_UP		MITOSIS					SHEPARD_CRUSH_AND_BURN_MUTANT_DN
699	BUB1	budding uninhibited by benzimidazoles 1 homolog (yeast)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN					AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2				ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE		MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN	WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
6241	RRM2	ribonucleotide reductase M2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION		MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53			FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3		ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP						MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
4001	LMNB1	lamin B1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP			WONG_EMBRYONIC_STEM_CELL_CORE				CROONQUIST_NRAS_SIGNALING_DN								MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN		TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118		MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP						MORI_PRE_BI_LYMPHOCYTE_UP							ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR						LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN			WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
7272	TTK	TTK protein kinase	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN			MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN				LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP			CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR			CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN					MITOSIS					SHEPARD_CRUSH_AND_BURN_MUTANT_DN
55165	CEP55	centrosomal protein 55kDa	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN					ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER					GAVIN_FOXP3_TARGETS_CLUSTER_P6				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN						GEORGES_TARGETS_OF_MIR192_AND_MIR215					POOLA_INVASIVE_BREAST_CANCER_UP					SMID_BREAST_CANCER_BASAL_UP			FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP							WHITFIELD_CELL_CYCLE_G2_M									KIM_WT1_TARGETS_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN										SHEPARD_CRUSH_AND_BURN_MUTANT_DN
11004	KIF2C	kinesin family member 2C	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK						POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN						JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049			LE_EGR2_TARGETS_UP			MITOSIS			REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
259266	ASPM	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN				CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP			KANG_DOXORUBICIN_RESISTANCE_UP		ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION			POOLA_INVASIVE_BREAST_CANCER_UP					SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2				ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN						CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2			WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP												SHEPARD_CRUSH_AND_BURN_MUTANT_DN
3832	KIF11	kinesin family member 11	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP		BENPORATH_CYCLING_GENES		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER				WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN		TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C			CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE						CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN		LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP		MITOSIS		WHITFIELD_CELL_CYCLE_G2			SHEPARD_CRUSH_AND_BURN_MUTANT_DN
4288	MKI67	antigen identified by monoclonal antibody Ki-67	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN			CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP		BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP				CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN							TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M					MORI_PRE_BI_LYMPHOCYTE_UP								MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN		LE_EGR2_TARGETS_UP							MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
9133	CCNB2	cyclin B2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2		MODULE_3		ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING		MORI_PRE_BI_LYMPHOCYTE_UP												WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN				REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
9232	PTTG1	pituitary tumor-transforming 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP					CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP			BLUM_RESPONSE_TO_SALIRASIB_DN						MODULE_52	PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE		SMID_BREAST_CANCER_BASAL_UP			FARMER_BREAST_CANCER_CLUSTER_2		MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN							FOURNIER_ACINAR_DEVELOPMENT_LATE_2			WEST_ADRENOCORTICAL_TUMOR_UP						MITSIADES_RESPONSE_TO_APLIDIN_DN									WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
2305	FOXM1	forkhead box M1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN					PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP		ZHAN_MULTIPLE_MYELOMA_PR_UP					CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN			MODULE_118		MODULE_53			FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN			MODULE_3	MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP						MITSIADES_RESPONSE_TO_APLIDIN_DN												MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
23397	NCAPH	non-SMC condensin I complex, subunit H	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE				CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN				PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN									SMID_BREAST_CANCER_BASAL_UP								JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE			MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE		MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049			LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP		MITOSIS		WHITFIELD_CELL_CYCLE_G2		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
55355	HJURP	Holliday junction recognition protein	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP					NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP					CAIRO_HEPATOBLASTOMA_CLASSES_UP															GEORGES_TARGETS_OF_MIR192_AND_MIR215																									FOURNIER_ACINAR_DEVELOPMENT_LATE_2					KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN										WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE		
3161	HMMR	hyaluronan-mediated motility receptor (RHAMM)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP			PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN			MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53					TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN								MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING		MORI_PRE_BI_LYMPHOCYTE_UP									SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN				GAL_LEUKEMIC_STEM_CELL_DN						
1058	CENPA	centromere protein A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP				CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53		AMUNDSON_GAMMA_RADIATION_RESPONSE		SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2		MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER			KIM_WT1_TARGETS_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			WHITFIELD_CELL_CYCLE_LITERATURE		BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN				REACTOME_CELL_CYCLE		
4751	NEK2	NIMA (never in mitosis gene a)-related kinase 2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP						GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN					BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP			AMUNDSON_GAMMA_RADIATION_RESPONSE		SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		FARMER_BREAST_CANCER_CLUSTER_2					JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049						MITOSIS			REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
3838	KPNA2	karyopherin alpha 2 (RAG cohort 1, importin alpha 1)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54			KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP				CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN					BENPORATH_PROLIFERATION					LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN									MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE			MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE		M_PHASE					CELL_CYCLE_GO_0007049			LE_EGR2_TARGETS_UP					WHITFIELD_CELL_CYCLE_G2			
1063	CENPF	centromere protein F, 350/400kDa (mitosin)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54				CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER					GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION		MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE		SMID_BREAST_CANCER_BASAL_UP				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN	WHITFIELD_CELL_CYCLE_LITERATURE		BIDUS_METASTASIS_UP						MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
9055	PRC1	protein regulator of cytokinesis 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP			KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN					BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP			AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP							SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN		LE_EGR2_TARGETS_UP							MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
24137	KIF4A	kinesin family member 4A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN					GOLDRATH_ANTIGEN_RESPONSE						BASAKI_YBX1_TARGETS_UP			KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				MARKEY_RB1_ACUTE_LOF_DN				FUJII_YBX1_TARGETS_DN		TANG_SENESCENCE_TP53_TARGETS_DN										FARMER_BREAST_CANCER_CLUSTER_2				ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C					CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP								MITSIADES_RESPONSE_TO_APLIDIN_DN						BIDUS_METASTASIS_UP							
29127	RACGAP1	Rac GTPase activating protein 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR				WINNEPENNINCKX_MELANOMA_METASTASIS_UP					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP			GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN			GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN						FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS			FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN		CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE		BIDUS_METASTASIS_UP							SHEPARD_CRUSH_AND_BURN_MUTANT_DN
64151	NCAPG	non-SMC condensin I complex, subunit G	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN			CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP			VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP						WINNEPENNINCKX_MELANOMA_METASTASIS_UP				KANG_DOXORUBICIN_RESISTANCE_UP				GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP							BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP						BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP							AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN												KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN			ZHANG_TLX_TARGETS_36HR_DN				GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
55388	MCM10	minichromosome maintenance complex component 10	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN				GOLDRATH_ANTIGEN_RESPONSE						BASAKI_YBX1_TARGETS_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3				GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN					GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN									SMID_BREAST_CANCER_BASAL_UP																											ZHANG_TLX_TARGETS_36HR_DN			BIDUS_METASTASIS_UP			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
146909	KIF18B	kinesin family member 18B	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP											WINNEPENNINCKX_MELANOMA_METASTASIS_UP									CAIRO_HEPATOBLASTOMA_CLASSES_UP									GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN																SMID_BREAST_CANCER_BASAL_UP				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP														WEST_ADRENOCORTICAL_TUMOR_UP						MITSIADES_RESPONSE_TO_APLIDIN_DN							GAL_LEUKEMIC_STEM_CELL_DN						
11339	OIP5	Opa interacting protein 5	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN				CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP				CROONQUIST_IL6_DEPRIVATION_DN					PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP					CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN							GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN							FUJII_YBX1_TARGETS_DN				POOLA_INVASIVE_BREAST_CANCER_UP													JOHNSTONE_PARVB_TARGETS_3_DN												KIM_WT1_TARGETS_DN															REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
11065	UBE2C	ubiquitin-conjugating enzyme E2C	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN			MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK				TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118		MODULE_53		AMUNDSON_GAMMA_RADIATION_RESPONSE			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18						CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE			MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049				BIDUS_METASTASIS_UP		MITOSIS		WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
890	CCNA2	cyclin A2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP			BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK				TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53		AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING			RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN	WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP	BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
1164	CKS2	CDC28 protein kinase regulatory subunit 2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES			LEE_EARLY_T_LYMPHOCYTE_UP		BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP					CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP			LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION		MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP				WHITFIELD_CELL_CYCLE_G2_M				FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER			KIM_WT1_TARGETS_DN						CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP								SHEPARD_CRUSH_AND_BURN_MUTANT_DN
1062	CENPE	centromere protein E, 312kDa	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		MODULE_54					MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP			WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP			PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			GAVIN_FOXP3_TARGETS_CLUSTER_P6		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN						PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN					AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE						CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN					MITOSIS				MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
10112	KIF20A	kinesin family member 20A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP				HORIUCHI_WTAP_TARGETS_DN			MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				MARKEY_RB1_ACUTE_LOF_DN			GEORGES_TARGETS_OF_MIR192_AND_MIR215			TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP				FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN	FARMER_BREAST_CANCER_CLUSTER_2											CHICAS_RB1_TARGETS_GROWING				WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR					WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN				REACTOME_CELL_CYCLE		
9768	KIAA0101	KIAA0101	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6			CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3				GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK					MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP							CHICAS_RB1_TARGETS_GROWING			RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP					ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN					LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN					MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
990	CDC6	cell division cycle 6 homolog (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP			BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN								FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN						JOHNSTONE_PARVB_TARGETS_3_DN				CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE						SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE		BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
29028	ATAD2	ATPase family, AAA domain containing 2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES			LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP						CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP			WHITEFORD_PEDIATRIC_CANCER_MARKERS			WINNEPENNINCKX_MELANOMA_METASTASIS_UP			PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP						LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION								SMID_BREAST_CANCER_BASAL_UP			FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN																									WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
51514	DTL	denticleless homolog (Drosophila)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP			ZHANG_TLX_TARGETS_60HR_DN				GOLDRATH_ANTIGEN_RESPONSE						BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER				WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3				GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN			GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION			POOLA_INVASIVE_BREAST_CANCER_UP									SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP					ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
10635	RAD51AP1	RAD51 associated protein 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK		KANG_DOXORUBICIN_RESISTANCE_UP					CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION			POOLA_INVASIVE_BREAST_CANCER_UP				FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN						CHICAS_RB1_TARGETS_GROWING						KIM_WT1_TARGETS_DN							ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
54821	ERCC6L	excision repair cross-complementing rodent repair deficiency, complementation group 6-like	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP				KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN				ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS															WONG_EMBRYONIC_STEM_CELL_CORE																	GEORGES_TARGETS_OF_MIR192_AND_MIR215																																		MITSIADES_RESPONSE_TO_APLIDIN_DN			ZHANG_TLX_TARGETS_36HR_DN			BIDUS_METASTASIS_UP					REACTOME_CELL_CYCLE		
55872	PBK	PDZ binding kinase	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN			MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS					WHITEFORD_PEDIATRIC_CANCER_MARKERS		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP				GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP							BLUM_RESPONSE_TO_SALIRASIB_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP						BENPORATH_PROLIFERATION	TANG_SENESCENCE_TP53_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP					SMID_BREAST_CANCER_BASAL_UP				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M							WEST_ADRENOCORTICAL_TUMOR_UP												BIDUS_METASTASIS_UP			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
9319	TRIP13	thyroid hormone receptor interactor 13	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP			BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			MARKEY_RB1_ACUTE_LOF_DN	MODULE_52		GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN			MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN			MODULE_3	MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M				FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER						ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN			ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
9212	AURKB	aurora kinase B	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN						PUJANA_BRCA2_PCC_NETWORK				TANG_SENESCENCE_TP53_TARGETS_DN				LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN			MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C											KIM_WT1_TARGETS_DN														WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
4605	MYBL2	v-myb myeloblastosis viral oncogene homolog (avian)-like 2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED					VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN		CROONQUIST_IL6_DEPRIVATION_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER				WONG_EMBRYONIC_STEM_CELL_CORE			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP			BLUM_RESPONSE_TO_SALIRASIB_DN						MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION		MODULE_118		MODULE_53				SMID_BREAST_CANCER_BASAL_UP					MODULE_3				TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP							RHODES_UNDIFFERENTIATED_CANCER						ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN									WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
10460	TACC3	transforming, acidic coiled-coil containing protein 3	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE								PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN																AMUNDSON_GAMMA_RADIATION_RESPONSE				AFFAR_YY1_TARGETS_DN									WHITFIELD_CELL_CYCLE_G2_M													MITSIADES_RESPONSE_TO_APLIDIN_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP												SHEPARD_CRUSH_AND_BURN_MUTANT_DN
991	CDC20	cell division cycle 20 homolog (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN			MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215			TANG_SENESCENCE_TP53_TARGETS_DN	MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING		MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER			KIM_WT1_TARGETS_DN						CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN				REACTOME_CELL_CYCLE		SHEPARD_CRUSH_AND_BURN_MUTANT_DN
51512	GTSE1	G-2 and S-phase expressed 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN				CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN			BERENJENO_TRANSFORMED_BY_RHOA_UP				CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK					MODULE_118		MODULE_53				SMID_BREAST_CANCER_BASAL_UP						MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING						KIM_WT1_TARGETS_DN											GAL_LEUKEMIC_STEM_CELL_DN						SHEPARD_CRUSH_AND_BURN_MUTANT_DN
55143	CDCA8	cell division cycle associated 8	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES								GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3																				SMID_BREAST_CANCER_BASAL_UP							ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN						CHICAS_RB1_TARGETS_GROWING						KIM_WT1_TARGETS_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	MITSIADES_RESPONSE_TO_APLIDIN_DN					LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN			WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE		
83461	CDCA3	cell division cycle associated 3	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES					KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE						BASAKI_YBX1_TARGETS_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6											MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN													SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN					ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M				FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN														WHITFIELD_CELL_CYCLE_G2			SHEPARD_CRUSH_AND_BURN_MUTANT_DN
899	CCNF	cyclin F	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54			KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES					KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN					MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN			MODULE_118		MODULE_53		AMUNDSON_GAMMA_RADIATION_RESPONSE			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C						FOURNIER_ACINAR_DEVELOPMENT_LATE_2					KIM_WT1_TARGETS_DN								WHITFIELD_CELL_CYCLE_LITERATURE						WHITFIELD_CELL_CYCLE_G2			
5347	PLK1	polo-like kinase 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6	CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		BURTON_ADIPOGENESIS_3		BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				MARKEY_RB1_ACUTE_LOF_DN	MODULE_52						MODULE_118		MODULE_53		AMUNDSON_GAMMA_RADIATION_RESPONSE				AFFAR_YY1_TARGETS_DN			MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2				CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE	LE_EGR2_TARGETS_UP		GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS			REACTOME_CELL_CYCLE		
9700	ESPL1	extra spindle pole bodies homolog 1 (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP								WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER													BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					MODULE_52	PUJANA_BRCA2_PCC_NETWORK								LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN					MODULE_18						CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE					WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE	KIM_WT1_TARGETS_DN	M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049					GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS		WHITFIELD_CELL_CYCLE_G2		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
6491	STIL	SCL/TAL1 interrupting locus	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP			DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES						CROONQUIST_IL6_DEPRIVATION_DN					PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK									CROONQUIST_NRAS_SIGNALING_DN				RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215											TARTE_PLASMA_CELL_VS_PLASMABLAST_DN								TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP									WHITFIELD_CELL_CYCLE_G2			
55723	ASF1B	ASF1 anti-silencing function 1 homolog B (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER				KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS				BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP									BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3							MARKEY_RB1_ACUTE_LOF_DN				FUJII_YBX1_TARGETS_DN								FEVR_CTNNB1_TARGETS_DN										TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP															SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP					BIDUS_METASTASIS_UP	GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
1033	CDKN3	cyclin-dependent kinase inhibitor 3	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN					BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN	MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION		MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP	MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3					MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE	CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2		RHODES_UNDIFFERENTIATED_CANCER		CELL_CYCLE_PHASE							CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE			GAL_LEUKEMIC_STEM_CELL_DN					MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
9156	EXO1	exonuclease 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN					ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP			BLUM_RESPONSE_TO_SALIRASIB_DN									FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION							FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP		AFFAR_YY1_TARGETS_DN					ZHENG_GLIOBLASTOMA_PLASTICITY_UP																ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
8438	RAD54L	RAD54-like (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP				MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			GAVIN_FOXP3_TARGETS_CLUSTER_P6		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN				PUJANA_BRCA2_PCC_NETWORK			BENPORATH_PROLIFERATION		MODULE_118		MODULE_53			FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP							ZHENG_GLIOBLASTOMA_PLASTICITY_UP		TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C			CELL_CYCLE_PROCESS							CELL_CYCLE_PHASE		M_PHASE		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR			CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
55635	DEPDC1	DEP domain containing 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN	CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR					BASAKI_YBX1_TARGETS_UP									LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN																				WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING	FOURNIER_ACINAR_DEVELOPMENT_LATE_2												ZHANG_TLX_TARGETS_36HR_DN			BIDUS_METASTASIS_UP							
995	CDC25C	cell division cycle 25 homolog C (S. pombe)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54				CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES								GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK							HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP				CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN		BERENJENO_TRANSFORMED_BY_RHOA_UP			BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN						LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN										CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE					WEST_ADRENOCORTICAL_TUMOR_UP	CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049		WHITFIELD_CELL_CYCLE_LITERATURE			GAL_LEUKEMIC_STEM_CELL_DN	MITOSIS		WHITFIELD_CELL_CYCLE_G2	REACTOME_CELL_CYCLE	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
81930	KIF18A	kinesin family member 18A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																CAIRO_HEPATOBLASTOMA_CLASSES_UP						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215									FEVR_CTNNB1_TARGETS_DN								ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN												KIM_WT1_TARGETS_DN							ZHANG_TLX_TARGETS_36HR_DN								REACTOME_CELL_CYCLE		
9221	NOLC1	nucleolar and coiled-body phosphoprotein 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN						KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED								ZHANG_TLX_TARGETS_60HR_DN							PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK							CAIRO_HEPATOBLASTOMA_CLASSES_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52									LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN						MODULE_3	MODULE_18						CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2				CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049						MITOSIS					
10024	TROAP	trophinin associated protein (tastin)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN						NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES											PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER													BLUM_RESPONSE_TO_SALIRASIB_DN							PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53					TARTE_PLASMA_CELL_VS_PLASMABLAST_DN																																				
57405	SPC25	SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN		KONG_E2F3_TARGETS	CROONQUIST_IL6_DEPRIVATION_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK				ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6			CROONQUIST_NRAS_SIGNALING_DN												PUJANA_BRCA2_PCC_NETWORK		FUJII_YBX1_TARGETS_DN				POOLA_INVASIVE_BREAST_CANCER_UP												ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN																			ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
220134	SKA1	spindle and kinetochore associated complex subunit 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP						MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP							ZHANG_TLX_TARGETS_60HR_DN															ZHAN_MULTIPLE_MYELOMA_PR_UP																		GEORGES_TARGETS_OF_MIR192_AND_MIR215									FEVR_CTNNB1_TARGETS_DN										TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																		ZHANG_TLX_TARGETS_36HR_DN								REACTOME_CELL_CYCLE		
284403	WDR62	WD repeat domain 62	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6					DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP								BENPORATH_CYCLING_GENES																																																																																	WHITFIELD_CELL_CYCLE_G2			
55789	DEPDC1B	DEP domain containing 1B	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN											BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER			ZHAN_MULTIPLE_MYELOMA_PR_UP																			FUJII_YBX1_TARGETS_DN													SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M																										
113130	CDCA5	cell division cycle associated 5	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP			ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS			WINNEPENNINCKX_MELANOMA_METASTASIS_UP			PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6					BERENJENO_TRANSFORMED_BY_RHOA_UP						MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN					BENPORATH_PROLIFERATION																		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE			MORI_PRE_BI_LYMPHOCYTE_UP			CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049						MITOSIS					
83540	NUF2	NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP			ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER			ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6							RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION							FEVR_CTNNB1_TARGETS_DN					SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M																						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
29128	UHRF1	ubiquitin-like with PHD and ring finger domains 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP			ZHANG_TLX_TARGETS_60HR_DN			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	WHITEFORD_PEDIATRIC_CANCER_MARKERS			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP												BERENJENO_TRANSFORMED_BY_RHOA_UP												FUJII_YBX1_TARGETS_DN											AFFAR_YY1_TARGETS_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN						CHICAS_RB1_TARGETS_GROWING									ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP				LE_EGR2_TARGETS_UP				WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
221150	SKA3	spindle and kinetochore associated complex subunit 3	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP						CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP																					RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																											JOHNSTONE_PARVB_TARGETS_3_DN																	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP									WHITFIELD_CELL_CYCLE_G2			
128239	IQGAP3	IQ motif containing GTPase activating protein 3	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP							NUYTTEN_EZH2_TARGETS_DN						KONG_E2F3_TARGETS		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE																		BERENJENO_TRANSFORMED_BY_RHOA_UP						MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN																					JOHNSTONE_PARVB_TARGETS_3_DN						CHICAS_RB1_TARGETS_GROWING															LE_EGR2_TARGETS_UP					WHITFIELD_CELL_CYCLE_G2			
90381	C15orf42	chromosome 15 open reading frame 42	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP							NUYTTEN_EZH2_TARGETS_DN																																						GEORGES_TARGETS_OF_MIR192_AND_MIR215																			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																								WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
151246	SGOL2	shugoshin-like 2 (S. pombe)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN			MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP			VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN				CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP						WINNEPENNINCKX_MELANOMA_METASTASIS_UP										LINDGREN_BLADDER_CANCER_CLUSTER_1_DN					RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215														SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN			WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING																					REACTOME_CELL_CYCLE		
146956	EME1	essential meiotic endonuclease 1 homolog 1 (S. pombe)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP						MARSON_BOUND_BY_E2F4_UNSTIMULATED								ZHANG_TLX_TARGETS_60HR_DN																																	GEORGES_TARGETS_OF_MIR192_AND_MIR215																		JOHNSTONE_PARVB_TARGETS_3_DN																													
23076	RRP1B	ribosomal RNA processing 1 homolog B (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP									NUYTTEN_EZH2_TARGETS_DN												PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK																				MODULE_52								MODULE_53			FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18																															
9824	ARHGAP11A	Rho GTPase activating protein 11A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN			MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP				MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN								PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK													RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									GEORGES_TARGETS_OF_MIR192_AND_MIR215																		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
1163	CKS1B	CDC28 protein kinase regulatory subunit 1B	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN			MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN		GOLDRATH_ANTIGEN_RESPONSE		WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE	GAVIN_FOXP3_TARGETS_CLUSTER_P6		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	CROONQUIST_NRAS_SIGNALING_DN	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP	BURTON_ADIPOGENESIS_3			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN				FUJII_YBX1_TARGETS_DN	BENPORATH_PROLIFERATION					LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN						ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	WHITFIELD_CELL_CYCLE_G2_M				FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER								SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049			LE_EGR2_TARGETS_UP				WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
84823	LMNB2	lamin B2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN			MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN										ZHANG_TLX_TARGETS_60HR_DN						WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP	PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER														CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52		GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53									MODULE_3	MODULE_18																															SHEPARD_CRUSH_AND_BURN_MUTANT_DN
157570	ESCO2	establishment of cohesion 1 homolog 2 (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN				DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP															PATIL_LIVER_CANCER																					GEORGES_TARGETS_OF_MIR192_AND_MIR215														SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN																									WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
55646	LYAR	Ly1 antibody reactive homolog (mouse)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN							CHANG_CYCLING_GENES					BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP			ZHANG_TLX_TARGETS_60HR_DN																								RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																									ZHANG_TLX_TARGETS_36HR_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
151648	SGOL1	shugoshin-like 1 (S. pombe)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN								MARSON_BOUND_BY_E2F4_UNSTIMULATED								ZHANG_TLX_TARGETS_60HR_DN														HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP																																																								ZHANG_TLX_TARGETS_36HR_DN								REACTOME_CELL_CYCLE		
64853	AIDA	axin interactor, dorsalization associated	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
9088	PKMYT1	protein kinase, membrane associated tyrosine/threonine 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP				SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN						BENPORATH_CYCLING_GENES											PUJANA_BRCA1_PCC_NETWORK					PATIL_LIVER_CANCER																			MODULE_52				BENPORATH_PROLIFERATION		MODULE_118		MODULE_53										MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C			CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE						CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049						MITOSIS	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
81610	FAM83D	family with sequence similarity 83, member D	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES				NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN											BASAKI_YBX1_TARGETS_UP									LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP												GEORGES_TARGETS_OF_MIR192_AND_MIR215																																												WHITFIELD_CELL_CYCLE_G2			
1104	RCC1	regulator of chromosome condensation 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54																				PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP				BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52						MODULE_118		MODULE_53									MODULE_3	MODULE_18	ZHENG_GLIOBLASTOMA_PLASTICITY_UP					CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE		FOURNIER_ACINAR_DEVELOPMENT_LATE_2				CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049						MITOSIS				MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
220042	C11orf82	chromosome 11 open reading frame 82	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES				NUYTTEN_EZH2_TARGETS_DN								CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP																																							FEVR_CTNNB1_TARGETS_DN																																		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
1870	E2F2	E2F transcription factor 2	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP						LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN																	PATIL_LIVER_CANCER																																																														GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
144455	E2F7	E2F transcription factor 7	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP						LEE_EARLY_T_LYMPHOCYTE_UP			VECCHI_GASTRIC_CANCER_EARLY_UP													BASAKI_YBX1_TARGETS_UP														RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP										FUJII_YBX1_TARGETS_DN																ZHENG_GLIOBLASTOMA_PLASTICITY_UP																										WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
150468	CKAP2L	cytoskeleton associated protein 2-like	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN				ODONNELL_TFRC_TARGETS_DN																																		GEORGES_TARGETS_OF_MIR192_AND_MIR215																			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																									WHITFIELD_CELL_CYCLE_G2			
147841	SPC24	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP							DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN			MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN															BASAKI_YBX1_TARGETS_UP					ZHAN_MULTIPLE_MYELOMA_PR_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6																																		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																								WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		REACTOME_CELL_CYCLE		
83903	GSG2	germ cell associated 2 (haspin)	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP											MARSON_BOUND_BY_E2F4_UNSTIMULATED			NUYTTEN_EZH2_TARGETS_DN					ZHANG_TLX_TARGETS_60HR_DN				GOLDRATH_ANTIGEN_RESPONSE																		BERENJENO_TRANSFORMED_BY_RHOA_UP											GEORGES_TARGETS_OF_MIR192_AND_MIR215									FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN							TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
729533	FAM72A	family with sequence similarity 72, member A	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP											MARSON_BOUND_BY_E2F4_UNSTIMULATED																																																																																								
26986	PABPC1	poly(A) binding protein, cytoplasmic 1	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP																										PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE																										FEVR_CTNNB1_TARGETS_DN																																						
9928	KIF14	kinesin family member 14		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN			CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN			CROONQUIST_IL6_DEPRIVATION_DN				WHITEFORD_PEDIATRIC_CANCER_MARKERS	PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK				ZHAN_MULTIPLE_MYELOMA_PR_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN								TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C		WHITFIELD_CELL_CYCLE_G2_M			CHICAS_RB1_TARGETS_GROWING			RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN				MITSIADES_RESPONSE_TO_APLIDIN_DN												MISSIAGLIA_REGULATED_BY_METHYLATION_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN
56992	KIF15	kinesin family member 15		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP				KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED		LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP																				CAIRO_HEPATOBLASTOMA_CLASSES_UP							BLUM_RESPONSE_TO_SALIRASIB_DN	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN						GEORGES_TARGETS_OF_MIR192_AND_MIR215					POOLA_INVASIVE_BREAST_CANCER_UP								FARMER_BREAST_CANCER_CLUSTER_2	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C			CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE						CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE				CELL_CYCLE_GO_0007049						MITOSIS					
79733	E2F8	E2F transcription factor 8		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		KOBAYASHI_EGFR_SIGNALING_24HR_DN			CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	LEE_EARLY_T_LYMPHOCYTE_UP	NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		ZHANG_TLX_TARGETS_60HR_DN				GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR							PATIL_LIVER_CANCER		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP						LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP						MORI_IMMATURE_B_LYMPHOCYTE_DN		MARKEY_RB1_ACUTE_LOF_DN			GEORGES_TARGETS_OF_MIR192_AND_MIR215																		JOHNSTONE_PARVB_TARGETS_3_DN		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP						MORI_PRE_BI_LYMPHOCYTE_UP							ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR								GAL_LEUKEMIC_STEM_CELL_DN		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
3159	HMGA1	high mobility group AT-hook 1		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6				MODULE_54		HORIUCHI_WTAP_TARGETS_DN								VECCHI_GASTRIC_CANCER_EARLY_UP					CROONQUIST_IL6_DEPRIVATION_DN					PUJANA_BRCA1_PCC_NETWORK					PATIL_LIVER_CANCER						CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_NRAS_SIGNALING_DN																							SMID_BREAST_CANCER_BASAL_UP																																					SHEPARD_CRUSH_AND_BURN_MUTANT_DN
10721	POLQ	polymerase (DNA directed), theta		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP				MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES										WHITEFORD_PEDIATRIC_CANCER_MARKERS							KANG_DOXORUBICIN_RESISTANCE_UP													CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215																									FOURNIER_ACINAR_DEVELOPMENT_LATE_2									MITSIADES_RESPONSE_TO_APLIDIN_DN										WHITFIELD_CELL_CYCLE_G2			
3833	KIFC1	kinesin family member C1		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES				NUYTTEN_EZH2_TARGETS_DN	BENPORATH_CYCLING_GENES						CROONQUIST_IL6_DEPRIVATION_DN			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK								LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					MODULE_52	PUJANA_BRCA2_PCC_NETWORK	GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	AMUNDSON_GAMMA_RADIATION_RESPONSE	FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C														ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR								GAL_LEUKEMIC_STEM_CELL_DN			WHITFIELD_CELL_CYCLE_G2		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
7804	LRP8	low density lipoprotein receptor-related protein 8, apolipoprotein e receptor		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER				KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN						NUYTTEN_EZH2_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP																																				GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION			POOLA_INVASIVE_BREAST_CANCER_UP					SMID_BREAST_CANCER_BASAL_UP																																	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
10797	MTHFD2	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54																CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WONG_EMBRYONIC_STEM_CELL_CORE			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP				MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP											LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	AFFAR_YY1_TARGETS_DN					ZHENG_GLIOBLASTOMA_PLASTICITY_UP	JOHNSTONE_PARVB_TARGETS_3_DN								MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER	WEST_ADRENOCORTICAL_TUMOR_UP																			
5366	PMAIP1	phorbol-12-myristate-13-acetate-induced protein 1			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54																				PUJANA_BRCA1_PCC_NETWORK																	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP														WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN																	
10606	PAICS	phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			HORIUCHI_WTAP_TARGETS_DN	KOBAYASHI_EGFR_SIGNALING_24HR_DN		MARSON_BOUND_BY_E2F4_UNSTIMULATED											CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		PUJANA_BRCA1_PCC_NETWORK		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		PUJANA_CHEK2_PCC_NETWORK													RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52	PUJANA_BRCA2_PCC_NETWORK					MODULE_118		MODULE_53			FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN							FOURNIER_ACINAR_DEVELOPMENT_LATE_2								ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR													MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
23636	NUP62	nucleoporin 62kDa			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																					PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK								LINDGREN_BLADDER_CANCER_CLUSTER_1_DN															FUJII_YBX1_TARGETS_DN		TANG_SENESCENCE_TP53_TARGETS_DN						FEVR_CTNNB1_TARGETS_DN																																						
8767	RIPK2	receptor-interacting serine-threonine kinase 2			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
3556	IL1RAP	interleukin 1 receptor accessory protein			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP							NUYTTEN_EZH2_TARGETS_DN																													RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52		GEORGES_TARGETS_OF_MIR192_AND_MIR215	FUJII_YBX1_TARGETS_DN			MODULE_118																																							WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
6950	TCP1	t-complex 1			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP						MARSON_BOUND_BY_E2F4_UNSTIMULATED															PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK																					PUJANA_BRCA2_PCC_NETWORK										FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN							JOHNSTONE_PARVB_TARGETS_3_DN										WEST_ADRENOCORTICAL_TUMOR_UP																			
30001	ERO1L	ERO1-like (S. cerevisiae)			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP														ZHANG_TLX_TARGETS_60HR_DN																										CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																															WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
1138	CHRNA5	cholinergic receptor, nicotinic, alpha 5			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6					DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																							PUJANA_CHEK2_PCC_NETWORK																		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			PUJANA_BRCA2_PCC_NETWORK																																																
10643	IGF2BP3	insulin-like growth factor 2 mRNA binding protein 3			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6										CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP														PUJANA_BRCA1_PCC_NETWORK					PATIL_LIVER_CANCER					GAVIN_FOXP3_TARGETS_CLUSTER_P6							RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52						MODULE_118		MODULE_53				SMID_BREAST_CANCER_BASAL_UP					MODULE_3	MODULE_18												WEST_ADRENOCORTICAL_TUMOR_UP		KIM_WT1_TARGETS_DN																	
10096	ACTR3	ARP3 actin-related protein 3 homolog (yeast)			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																								PUJANA_BRCA1_PCC_NETWORK																			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																																						
5238	PGM3	phosphoglucomutase 3			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																																						LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
54442	KCTD5	potassium channel tetramerisation domain containing 5			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																																									RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																																			
81621	KAZALD1	Kazal-type serine peptidase inhibitor domain 1			SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																																																																																																	
11260	XPOT	exportin, tRNA (nuclear export receptor for tRNAs)				DODD_NASOPHARYNGEAL_CARCINOMA_DN	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP																		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP				PUJANA_BRCA1_PCC_NETWORK					PATIL_LIVER_CANCER									LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN																					WEST_ADRENOCORTICAL_TUMOR_UP																			
54443	ANLN	anillin, actin binding protein				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	HORIUCHI_WTAP_TARGETS_DN		CHANG_CYCLING_GENES	MARSON_BOUND_BY_E2F4_UNSTIMULATED	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP			BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN				GOLDRATH_ANTIGEN_RESPONSE	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR				WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP								BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	MARKEY_RB1_ACUTE_LOF_DN			GEORGES_TARGETS_OF_MIR192_AND_MIR215		BENPORATH_PROLIFERATION												SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			ZHENG_GLIOBLASTOMA_PLASTICITY_UP				WHITFIELD_CELL_CYCLE_G2_M	CELL_CYCLE_PROCESS	MITOTIC_CELL_CYCLE						CELL_CYCLE_PHASE		M_PHASE	M_PHASE_OF_MITOTIC_CELL_CYCLE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	CELL_CYCLE_GO_0007049	ZHANG_TLX_TARGETS_36HR_DN					MITOSIS		WHITFIELD_CELL_CYCLE_G2			SHEPARD_CRUSH_AND_BURN_MUTANT_DN
7371	UCK2	uridine-cytidine kinase 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP				KOBAYASHI_EGFR_SIGNALING_24HR_DN										ZHANG_TLX_TARGETS_60HR_DN							PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP				MORI_IMMATURE_B_LYMPHOCYTE_DN	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52									LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			SMID_BREAST_CANCER_BASAL_UP	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				MODULE_3	MODULE_18									FOURNIER_ACINAR_DEVELOPMENT_LATE_2										SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP												
116028	RMI2	RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP							CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		NUYTTEN_EZH2_TARGETS_DN																										LINDGREN_BLADDER_CANCER_CLUSTER_3_UP																																																											
27101	CACYBP	calcyclin binding protein				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR				WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BASAKI_YBX1_TARGETS_UP												BERENJENO_TRANSFORMED_BY_RHOA_UP							RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																												CHICAS_RB1_TARGETS_GROWING																							
4841	NONO	non-POU domain containing, octamer-binding				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																					PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																															BIDUS_METASTASIS_UP							
81875	ISG20L2	interferon stimulated exonuclease gene 20kDa-like 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																					PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK																																																																					
9015	TAF1A	TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																							WINNEPENNINCKX_MELANOMA_METASTASIS_UP																																																																							
81034	SLC25A32	solute carrier family 25, member 32				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																											RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP					FUJII_YBX1_TARGETS_DN												FARMER_BREAST_CANCER_CLUSTER_2					JOHNSTONE_PARVB_TARGETS_3_DN																													
8475	EPR1	---				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																																FUJII_YBX1_TARGETS_DN										TARTE_PLASMA_CELL_VS_PLASMABLAST_DN																																				
100	ADA	adenosine deaminase				DODD_NASOPHARYNGEAL_CARCINOMA_DN			MODULE_54							LEE_EARLY_T_LYMPHOCYTE_UP													PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK																					PUJANA_BRCA2_PCC_NETWORK					MODULE_118		MODULE_53			FEVR_CTNNB1_TARGETS_DN																																						
79709	GLT25D1	glycosyltransferase 25 domain containing 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN				DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																									RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																							TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C						FOURNIER_ACINAR_DEVELOPMENT_LATE_2																						
4673	NAP1L1	nucleosome assembly protein 1-like 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN					HORIUCHI_WTAP_TARGETS_DN											ZHANG_TLX_TARGETS_60HR_DN							PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER				WONG_EMBRYONIC_STEM_CELL_CORE														MARKEY_RB1_ACUTE_LOF_DN										LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN					SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	MODULE_3																									BIDUS_METASTASIS_UP							
51060	TXNDC12	thioredoxin domain containing 12 (endoplasmic reticulum)				DODD_NASOPHARYNGEAL_CARCINOMA_DN								MARSON_BOUND_BY_E2F4_UNSTIMULATED																																																																																								
23531	MMD	monocyte to macrophage differentiation-associated				DODD_NASOPHARYNGEAL_CARCINOMA_DN									CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP																																						MODULE_52																																				MITSIADES_RESPONSE_TO_APLIDIN_DN													
126129	CPT1C	carnitine palmitoyltransferase 1C				DODD_NASOPHARYNGEAL_CARCINOMA_DN											NUYTTEN_EZH2_TARGETS_DN																																																																																					
84733	CBX2	chromobox homolog 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN													VECCHI_GASTRIC_CANCER_EARLY_UP				KONG_E2F3_TARGETS											PATIL_LIVER_CANCER																																																																				
3601	IL15RA	interleukin 15 receptor, alpha				DODD_NASOPHARYNGEAL_CARCINOMA_DN													VECCHI_GASTRIC_CANCER_EARLY_UP																																																																																			
9562	MINPP1	multiple inositol-polyphosphate phosphatase 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN														GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP																													GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN																				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																											GAL_LEUKEMIC_STEM_CELL_DN						
10962	MLLT11	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11				DODD_NASOPHARYNGEAL_CARCINOMA_DN																			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP			WHITEFORD_PEDIATRIC_CANCER_MARKERS		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP																							MODULE_52			FUJII_YBX1_TARGETS_DN			MODULE_118		MODULE_53				SMID_BREAST_CANCER_BASAL_UP					MODULE_3	MODULE_18																															
2590	GALNT2	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)				DODD_NASOPHARYNGEAL_CARCINOMA_DN																							PUJANA_BRCA1_PCC_NETWORK			BASAKI_YBX1_TARGETS_UP															BLUM_RESPONSE_TO_SALIRASIB_DN																																																							
51582	AZIN1	antizyme inhibitor 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN																							PUJANA_BRCA1_PCC_NETWORK							HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP																																																											BIDUS_METASTASIS_UP							
1290	COL5A2	collagen, type V, alpha 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN																												PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN												MODULE_52						MODULE_118	POOLA_INVASIVE_BREAST_CANCER_UP									SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																																	
10010	TANK	TRAF family member-associated NFKB activator				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																								RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																																			
1277	COL1A1	collagen, type I, alpha 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																									BLUM_RESPONSE_TO_SALIRASIB_DN																						SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																KIM_WT1_TARGETS_DN																	
1293	COL6A3	collagen, type VI, alpha 3				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																														MARKEY_RB1_ACUTE_LOF_DN								POOLA_INVASIVE_BREAST_CANCER_UP							AFFAR_YY1_TARGETS_DN																																			
1281	COL3A1	collagen, type III, alpha 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																						POOLA_INVASIVE_BREAST_CANCER_UP									SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP										CHICAS_RB1_TARGETS_GROWING																							
3915	LAMC1	laminin, gamma 1 (formerly LAMB2)				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																															SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																																	
57621	ZBTB2	zinc finger and BTB domain containing 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
10228	STX6	syntaxin 6				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
58505	OSTC	oligosaccharyltransferase complex subunit				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
10963	STIP1	stress-induced-phosphoprotein 1					SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP									NUYTTEN_EZH2_TARGETS_DN																					WONG_EMBRYONIC_STEM_CELL_CORE						BERENJENO_TRANSFORMED_BY_RHOA_UP		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																	SMID_BREAST_CANCER_BASAL_UP																				KIM_WT1_TARGETS_DN																	
6713	SQLE	squalene epoxidase						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	MODULE_54		HORIUCHI_WTAP_TARGETS_DN															GOLDRATH_ANTIGEN_RESPONSE			PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER				WONG_EMBRYONIC_STEM_CELL_CORE		CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN							CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN												POOLA_INVASIVE_BREAST_CANCER_UP							AFFAR_YY1_TARGETS_DN			MODULE_3										FOURNIER_ACINAR_DEVELOPMENT_LATE_2	MORI_PRE_BI_LYMPHOCYTE_UP		WEST_ADRENOCORTICAL_TUMOR_UP												BIDUS_METASTASIS_UP			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN				
7163	TPD52	tumor protein D52						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP									PATIL_LIVER_CANCER														CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																																						
6675	UAP1	UDP-N-acteylglucosamine pyrophosphorylase 1						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP																																													MODULE_3			JOHNSTONE_PARVB_TARGETS_3_DN							FOURNIER_ACINAR_DEVELOPMENT_LATE_2																						
6573	SLC19A1	solute carrier family 19 (folate transporter), member 1						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																					PUJANA_BRCA1_PCC_NETWORK								ZHAN_MULTIPLE_MYELOMA_PR_UP																											FEVR_CTNNB1_TARGETS_DN		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN																																				
10959	TMED2	transmembrane emp24 domain trafficking protein 2						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																										PATIL_LIVER_CANCER																																																																				
57030	SLC17A7	solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																																																																														
51050	PI15	peptidase inhibitor 15						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																																																																														
10549	PRDX4	peroxiredoxin 4							MODULE_54											GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP						GOLDRATH_ANTIGEN_RESPONSE														CAIRO_HEPATOBLASTOMA_CLASSES_UP			LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN														FEVR_CTNNB1_TARGETS_DN			AFFAR_YY1_TARGETS_DN								MORI_LARGE_PRE_BII_LYMPHOCYTE_UP						MORI_PRE_BI_LYMPHOCYTE_UP	RHODES_UNDIFFERENTIATED_CANCER																				
374393	FAM111B	family with sequence similarity 111, member B								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP			CHANG_CYCLING_GENES																																										GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
54898	ELOVL2	ELOVL fatty acid elongase 2								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP												ZHANG_TLX_TARGETS_60HR_DN																																								LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN									MODULE_18								CHICAS_RB1_TARGETS_GROWING																							
84187	TMEM164	transmembrane protein 164								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																													GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
8839	WISP2	WNT1 inducible signaling pathway protein 2								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																																									AFFAR_YY1_TARGETS_DN																																			
23089	PEG10	paternally expressed 10									HORIUCHI_WTAP_TARGETS_DN																							PATIL_LIVER_CANCER												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP							MODULE_52						MODULE_118		MODULE_53				SMID_BREAST_CANCER_BASAL_UP						MODULE_18																															
653820	FAM72B	family with sequence similarity 72, member B											CHANG_CYCLING_GENES																					PATIL_LIVER_CANCER																																																																	WHITFIELD_CELL_CYCLE_G2			
6464	SHC1	SHC (Src homology 2 domain containing) transforming protein 1												MARSON_BOUND_BY_E2F4_UNSTIMULATED				BENPORATH_CYCLING_GENES																PATIL_LIVER_CANCER																																																																				
8357	HIST1H3H	histone cluster 1, H3h												MARSON_BOUND_BY_E2F4_UNSTIMULATED																													LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																								
2000	ELF4	E74-like factor 4 (ets domain transcription factor)													CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP																															RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																			SMID_BREAST_CANCER_BASAL_UP					MODULE_3													WEST_ADRENOCORTICAL_TUMOR_UP																			
7504	XK	X-linked Kx blood group (McLeod syndrome)															NUYTTEN_EZH2_TARGETS_DN			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP																													GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN						GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
23657	SLC7A11	solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11															NUYTTEN_EZH2_TARGETS_DN																													RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52		GEORGES_TARGETS_OF_MIR192_AND_MIR215				MODULE_118		MODULE_53										MODULE_18		JOHNSTONE_PARVB_TARGETS_3_DN	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C									WEST_ADRENOCORTICAL_TUMOR_UP																			
10683	DLL3	delta-like 3 (Drosophila)															NUYTTEN_EZH2_TARGETS_DN																																																																																					
7020	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)																BENPORATH_CYCLING_GENES	VECCHI_GASTRIC_CANCER_EARLY_UP																											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																									MODULE_18																												WHITFIELD_CELL_CYCLE_G2			
9643	MORF4L2	mortality factor 4 like 2																BENPORATH_CYCLING_GENES																												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																								
2191	FAP	fibroblast activation protein, alpha																			ODONNELL_TFRC_TARGETS_DN																																							POOLA_INVASIVE_BREAST_CANCER_UP																			CHICAS_RB1_TARGETS_GROWING																							
256126	SYCE2	synaptonemal complex central element protein 2																				ZHANG_TLX_TARGETS_60HR_DN	KONG_E2F3_TARGETS			GOLDRATH_ANTIGEN_RESPONSE																																																																												
170954	PPP1R18	protein phosphatase 1, regulatory subunit 18																				ZHANG_TLX_TARGETS_60HR_DN																																	GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
8728	ADAM19	ADAM metallopeptidase domain 19																							CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP				PUJANA_BRCA1_PCC_NETWORK												LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																		MODULE_118		MODULE_53																																									
8682	PEA15	phosphoprotein enriched in astrocytes 15																							CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP									PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																																																													
7291	TWIST1	twist homolog 1 (Drosophila)																										WHITEFORD_PEDIATRIC_CANCER_MARKERS																																																																										
1176	AP3S1	adaptor-related protein complex 3, sigma 1 subunit																											PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK	PATIL_LIVER_CANCER																																																																				
7528	YY1	YY1 transcription factor																											PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK					WONG_EMBRYONIC_STEM_CELL_CORE																																																																
6045	RNF2	ring finger protein 2																											PUJANA_BRCA1_PCC_NETWORK				PUJANA_CHEK2_PCC_NETWORK																																																																					
5279	PIGC	phosphatidylinositol glycan anchor biosynthesis, class C																											PUJANA_BRCA1_PCC_NETWORK					PATIL_LIVER_CANCER									LINDGREN_BLADDER_CANCER_CLUSTER_3_UP																												MODULE_18																															
1968	EIF2S3	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa																											PUJANA_BRCA1_PCC_NETWORK									WONG_EMBRYONIC_STEM_CELL_CORE										CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP													FEVR_CTNNB1_TARGETS_DN							MODULE_18																															
8761	PABPC4	poly(A) binding protein, cytoplasmic 4 (inducible form)																											PUJANA_BRCA1_PCC_NETWORK											CAIRO_HEPATOBLASTOMA_CLASSES_UP															GEORGES_TARGETS_OF_MIR192_AND_MIR215																			TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
5831	PYCR1	pyrroline-5-carboxylate reductase 1																											PUJANA_BRCA1_PCC_NETWORK												LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP																																																											
10728	PTGES3	prostaglandin E synthase 3 (cytosolic)																											PUJANA_BRCA1_PCC_NETWORK															BERENJENO_TRANSFORMED_BY_RHOA_UP								MARKEY_RB1_ACUTE_LOF_DN																												FOURNIER_ACINAR_DEVELOPMENT_LATE_2															BIDUS_METASTASIS_UP							
3428	IFI16	interferon, gamma-inducible protein 16																											PUJANA_BRCA1_PCC_NETWORK																	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52												SMID_BREAST_CANCER_BASAL_UP					MODULE_3	MODULE_18								CHICAS_RB1_TARGETS_GROWING						KIM_WT1_TARGETS_DN																	
5033	P4HA1	prolyl 4-hydroxylase, alpha polypeptide I																											PUJANA_BRCA1_PCC_NETWORK																						RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																												BIDUS_METASTASIS_UP							
1291	COL6A1	collagen, type VI, alpha 1																											PUJANA_BRCA1_PCC_NETWORK																																																																									
4885	NPTX2	neuronal pentraxin II																												NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP																																			SMID_BREAST_CANCER_BASAL_UP																		WEST_ADRENOCORTICAL_TUMOR_UP																			
333	APLP1	amyloid beta (A4) precursor-like protein 1																												NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP																																										ZHENG_GLIOBLASTOMA_PLASTICITY_UP																														
3309	HSPA5	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)																													WINNEPENNINCKX_MELANOMA_METASTASIS_UP																																																						KIM_WT1_TARGETS_DN																	
6836	SURF4	surfeit 4																													WINNEPENNINCKX_MELANOMA_METASTASIS_UP																																																																							
23623	RUSC1	RUN and SH3 domain containing 1																														BASAKI_YBX1_TARGETS_UP		PATIL_LIVER_CANCER																																																																				
7534	YWHAZ	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide																																PATIL_LIVER_CANCER						CAIRO_HEPATOBLASTOMA_CLASSES_UP						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP											LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		FEVR_CTNNB1_TARGETS_DN	SMID_BREAST_CANCER_BASAL_UP									TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
8751	ADAM15	ADAM metallopeptidase domain 15																																PATIL_LIVER_CANCER							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																																																													
157506	RDH10	retinol dehydrogenase 10 (all-trans)																																PATIL_LIVER_CANCER																						FUJII_YBX1_TARGETS_DN																																														
5546	PRCC	papillary renal cell carcinoma (translocation-associated)																																PATIL_LIVER_CANCER																																					MODULE_18																															
84918	LRP11	low density lipoprotein receptor-related protein 11																																PATIL_LIVER_CANCER																																								TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
871	SERPINH1	serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)																																				WONG_EMBRYONIC_STEM_CELL_CORE								RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		MODULE_52												SMID_BREAST_CANCER_BASAL_UP					MODULE_3	MODULE_18																															
5887	RAD23B	RAD23 homolog B (S. cerevisiae)																																				WONG_EMBRYONIC_STEM_CELL_CORE										CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN								FUJII_YBX1_TARGETS_DN																											WEST_ADRENOCORTICAL_TUMOR_UP																			
5034	P4HB	prolyl 4-hydroxylase, beta polypeptide																																						CAIRO_HEPATOBLASTOMA_CLASSES_UP	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																																																													
5396	PRRX1	paired related homeobox 1																																							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																																																													
285973	ATG9B	ATG9 autophagy related 9 homolog B (S. cerevisiae)																																							LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																																																													
115908	CTHRC1	collagen triple helix repeat containing 1																																												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																								
79843	FAM124B	family with sequence similarity 124B																																														CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																																						
8406	SRPX	sushi-repeat containing protein, X-linked																																																			MODULE_52						MODULE_118											MODULE_3	MODULE_18																															
389136	VGLL3	vestigial like 3 (Drosophila)																																																					GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
24145	PANX1	pannexin 1																																																					GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
5351	PLOD1	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1																																																					GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
284018	C17orf58	chromosome 17 open reading frame 58																																																					GEORGES_TARGETS_OF_MIR192_AND_MIR215																																															
10149	GPR64	G protein-coupled receptor 64																																																															SMID_BREAST_CANCER_BASAL_UP																																					
3755	KCNG1	potassium voltage-gated channel, subfamily G, member 1																																																															SMID_BREAST_CANCER_BASAL_UP																																					
117584	RFFL	ring finger and FYVE-like domain containing 1																																																																							JOHNSTONE_PARVB_TARGETS_3_DN																													
23471	TRAM1	translocation associated membrane protein 1																																																																							JOHNSTONE_PARVB_TARGETS_3_DN																													
118738	ZNF488	zinc finger protein 488																																																																								TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
728833	FAM72D	family with sequence similarity 72, member D																																																																								TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C																												
1292	COL6A2	collagen, type VI, alpha 2																																																																																														GAL_LEUKEMIC_STEM_CELL_DN						
1573	CYP2J2	cytochrome P450, family 2, subfamily J, polypeptide 2																																																																																																			MISSIAGLIA_REGULATED_BY_METHYLATION_DN	
2020	EN2	engrailed homeobox 2																																																																																																				SHEPARD_CRUSH_AND_BURN_MUTANT_DN
10882	C1QL1	complement component 1, q subcomponent-like 1																																																																																																				
5125	PCSK5	proprotein convertase subtilisin/kexin type 5																																																																																																				
169714	QSOX2	quiescin Q6 sulfhydryl oxidase 2																																																																																																				
7170	TPM3	tropomyosin 3																																																																																																				
90853	SPOCD1	SPOC domain containing 1																																																																																																				
2002	ELK1	ELK1, member of ETS oncogene family																																																																																																				
607	BCL9	B-cell CLL/lymphoma 9																																																																																																				
2306	FOXD2	forkhead box D2																																																																																																				
387521	TMEM189	transmembrane protein 189																																																																																																				
84923	FAM104A	family with sequence similarity 104, member A																																																																																																				
23139	MAST2	microtubule associated serine/threonine kinase 2																																																																																																				
9253	NUMBL	numb homolog (Drosophila)-like																																																																																																				
79651	RHBDF2	rhomboid 5 homolog 2 (Drosophila)																																																																																																				
53833	IL20RB	interleukin 20 receptor beta																																																																																																				
145864	HAPLN3	hyaluronan and proteoglycan link protein 3																																																																																																				
51094	ADIPOR1	adiponectin receptor 1																																																																																																				
26468	LHX6	LIM homeobox 6																																																																																																				
5042	PABPC3	poly(A) binding protein, cytoplasmic 3																																																																																																				
9096	TBX18	T-box 18																																																																																																				
146664	MGAT5B	mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B																																																																																																				
55974	SLC50A1	solute carrier family 50 (sugar transporter), member 1																																																																																																				
4007	PRICKLE3	prickle homolog 3 (Drosophila)																																																																																																				
7355	SLC35A2	solute carrier family 35 (UDP-galactose transporter), member A2																																																																																																				
6262	RYR2	ryanodine receptor 2 (cardiac)																																																																																																				
148113	CILP2	cartilage intermediate layer protein 2																																																																																																				
57835	SLC4A5	solute carrier family 4, sodium bicarbonate cotransporter, member 5																																																																																																				
339210	C17orf67	chromosome 17 open reading frame 67																																																																																																				
646024	RAET1K	retinoic acid early transcript 1K pseudogene																																																																																																				
414149	ACBD7	acyl-CoA binding domain containing 7																																																																																																				
399815	LOC399815	chromosome 10 open reading frame 88 pseudogene																																																																																																				
